Squarepoint’s Black Diamond Therapeutics BDTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$32.5K Buy
15,280
+528
+4% +$1.26K ﹤0.01% 4165
2025
Q4
$35.8K Sell
14,752
-2,429
-14% -$8.6K ﹤0.01% 4145
2025
Q3
$65.1K Sell
17,181
-66,295
-79% -$194K ﹤0.01% 4187
2025
Q2
$207K Buy
83,476
+61,018
+272% +$118K ﹤0.01% 3961
2025
Q1
$34.8K Sell
22,458
-109,416
-83% -$229K ﹤0.01% 4394
2024
Q4
$282K Buy
131,874
+72,688
+123% +$208K ﹤0.01% 4198
2024
Q3
$257K Buy
59,186
+33,835
+133% +$184K ﹤0.01% 3552
2024
Q2
$118K Sell
25,351
-146,025
-85% -$784K ﹤0.01% 3764
2024
Q1
$869K Buy
171,376
+26,524
+18% +$107K ﹤0.01% 2688
2023
Q4
$407K Buy
+144,852
New +$340K ﹤0.01% 3158
2022
Q1
Sell
-18,674
Closed -$100K 2826
2021
Q4
$100K Sell
18,674
-1,418
-7% -$9.91K ﹤0.01% 2914
2021
Q3
$170K Buy
+20,092
New +$198K ﹤0.01% 2546
2021
Q2
Sell
-59,863
Closed -$1.45M 3223
2021
Q1
$1.45M Buy
59,863
+29,429
+97% +$794K 0.01% 1263
2020
Q4
$975K Buy
+30,434
New +$1,000K 0.01% 1354

Other funds holding BDTX